Key Clinical MessageĀ 
We highlight the immunological hypothesis of PTS post-covid-19 BNT162b2 mRNA vaccine.
The prevalence of PTS post-vaccination is most likely to increase with covid-19 vaccines.
Early recognition is necessary for adequate treatment.